Afya Limited (NASDAQ:AFYA - Get Free Report)'s share price reached a new 52-week low on Thursday. The company traded as low as $9.95 and last traded at $10.15, with a volume of 135,001 shares changing hands. The stock had previously closed at $10.24.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on AFYA shares. Weiss Ratings cut shares of Afya from a "hold (c)" rating to a "hold (c-)" rating in a report on Friday, July 31st. JPMorgan Chase & Co. upgraded Afya from a "neutral" rating to an "overweight" rating and cut their target price for the company from $21.00 to $19.00 in a report on Wednesday, October 7th. Wall Street Zen raised Afya from a "hold" rating to a "buy" rating in a research report on Saturday, September 5th. Bradesco Corretora upgraded Afya to an "outperform" rating and set a $17.00 price target for the company in a research note on Thursday, September 24th. Finally, Bank of America upgraded Afya from a "neutral" rating to a "buy" rating and set a $16.00 price target for the company in a research note on Thursday. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $17.00.
Read Our Latest Report on AFYA
Afya Price Performance
The stock's 50 day moving average price is $13.77 and its two-hundred day moving average price is $14.24. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The firm has a market capitalization of $952.69 million, a price-to-earnings ratio of 6.19, a PEG ratio of 1.83 and a beta of 0.34.
Afya (NASDAQ:AFYA - Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The business had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. On average, equities research analysts anticipate that Afya Limited will post 1.72 EPS for the current year.
Insider Activity at Afya
In related news, insider Santos Welder Ferreira sold 4,161 shares of the business's stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the transaction, the insider owned 35,000 shares of the company's stock, valued at approximately $465,500. The trade was a 10.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Institutional Trading of Afya
An institutional investor recently bought a new position in Afya stock. Public Employees Retirement System of Ohio purchased a new position in shares of Afya Limited (NASDAQ:AFYA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,500 shares of the company's stock, valued at approximately $67,000. Institutional investors own 88.02% of the company's stock.
About Afya
(
Get Free Report)
Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.
Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.
The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
